Juan Jose Garcia Sanchez (Juan-Jose Garcia Sanchez, Juan José García Sánchez)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Advances in therapy

Diabetes therapy : research, treatment and education of diabetes and related disorders

Health and quality of life outcomes

Journal of medical economics

AstraZeneca Global

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca Global

United Kingdom

Health Economics and Payer Evidence Lead :: Health Economics

Publications

Lise Retat, Dunming Xiao, Laura Webber, Alexander Martin, Joshua Card-Gowers, Jiaqi Yao, Yuzheng Zhang, Chalet Zhang, Juan Jose Garcia Sanchez, Claudia Cabrera, Susan Grandy, Naveen Rao, Yiqing Wu, Zuo Li, Jianwei Xuan
Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population. Advances in therapy (2024)
Gérard de Pouvourville, Patrick Rossignol, Meriem Boussahoua, Julie Chevalier, Peter D Gabb, Roch Poulnais, Dorian Verboux, Naveen Rao, Elisabeth Sörstadius, Juan Jose Garcia Sanchez
Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective. Advances in therapy (2023)
Bartholomeus J A Willigers, Mario Ouwens, Andrew H Briggs, Hiddo J L Heerspink, Carol A Pollock, Roberto Flavio Pecoits-Filho, Navdeep Tangri, Csaba Pal Kovesdy, David Collins Wheeler, Juan Jose Garcia Sanchez
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial. Advances in therapy (2023)
Vivekanand Jha, Saeed M G Al-Ghamdi, Guisen Li, Mai-Szu Wu, Panagiotis Stafylas, Lise Retat, Joshua Card-Gowers, Salvatore Barone, Claudia Cabrera, Juan Jose Garcia Sanchez
Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme. Advances in therapy (2023)
Phil McEwan, Marco Hafner, Vivekenand Jha, Ricardo Correa-Rotter, Gil Chernin, Luca De Nicola, Russell Villanueva, David C Wheeler, Salvatore Barone, Stephen Nolan, Juan Jose Garcia Sanchez
Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis. Journal of medical economics (2023)
Johannes Pöhlmann, Klas Bergenheim, Juan Jose Garcia Sanchez, Naveen Rao, Andrew H Briggs, Richard F Pollock
Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (4) (2022)
Navdeep Tangri, Steven Chadban, Claudia Cabrera, Lise Retat, Juan Jose Garcia Sanchez
Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD. Advances in therapy (2022)
Jacie T Cooper, Andrew J Lloyd, Juan Jose Garcia Sanchez, Elisabeth Sörstadius, Andrew Briggs, Phil McFarlane
Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review. Health and quality of life outcomes 18 (1) (2020)

Juan Jose Garcia Sanchez.css-eqlu8i{font-size:small;padding-left:4px;} (Juan-Jose Garcia Sanchez, Juan José García Sánchez)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Jose Garcia Sanchez (Juan-Jose Garcia Sanchez, Juan José García Sánchez)